Medlive Technology Co., Ltd. (HK:2192) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Medlive Technology Co., Ltd. reports a robust first half with a 40.3% increase in revenue and a 50.2% surge in profits for the six-month period ending June 30, 2024, compared to the previous year. The company’s profit attributable to its owners saw a 48.6% rise, while its adjusted net profit grew by 30.3%. The growth was primarily driven by a significant uptick in precision marketing and corporate solutions, which constitute 92.6% of total revenue.
For further insights into HK:2192 stock, check out TipRanks’ Stock Analysis page.

